Loading…

Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor

Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca release from intac...

Full description

Saved in:
Bibliographic Details
Published in:Molecular pharmacology 2019-09, Vol.96 (3), p.401-407
Main Authors: Diszházi, Gyula, Magyar, Zsuzsanna Édua, Mótyán, János András, Csernoch, László, Jóna, István, Nánási, Péter Pál, Almássy, János
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883
cites cdi_FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883
container_end_page 407
container_issue 3
container_start_page 401
container_title Molecular pharmacology
container_volume 96
creator Diszházi, Gyula
Magyar, Zsuzsanna Édua
Mótyán, János András
Csernoch, László
Jóna, István
Nánási, Péter Pál
Almássy, János
description Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers. Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purification procedure of RyR. Recently, Mg was demonstrated to be the essential factor for dantrolene to inhibit Ca release in skinned muscle fibers. The aim of the present study was to confirm these results in Ca release and bilayer experiments, using SR vesicles and solubilized channels, respectively. Our Ca release experiments demonstrated that the effect of dantrolene and Mg was cooperative and that ATP enhanced the inhibiting effect of dantrolene. Namely, 10 M dantrolene reduced RyR channel open probability by ∼50% in the presence of 3 mM free Mg and 1 mM ATP, whereas channel activity further decreased to ∼20% of control when [ATP] was increased to 2 mM. Our data provide important complementary information that supports the direct, Mg -dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.
doi_str_mv 10.1124/mol.119.116475
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1124_mol_119_116475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31337666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883</originalsourceid><addsrcrecordid>eNo9kM1Lw0AQxRdRbK1ePcreJXVnN_uRY6lVCxVFIngLu5uJjbRJ3KSH_veuVj0M82B-b-A9Qi6BTQF4erNtN1FkcVSq5REZg-SQMAA4JmPGuEpMJt9G5KzvPxiDVBp2SkYChNBKqTGZ39pmCO0GG6Qv-LmrA_b08Z3ya2qbks7yZ5q3dNmsa1cPdFhHam-btqx_eI_d0IZzclLZTY8Xv3tCXu8W-fwhWT3dL-ezVeKBaZVoXmqhnasg414ap8BU2nCPHBFZ6dB4LZWq4j0D5zPURionLbNMgDJGTMj08NeHtu8DVkUX6q0N-wJY8d1GEduIIisObUTD1cHQ7dwWy3_8L774Ah3mWWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor</title><source>Free Full-Text Journals in Chemistry</source><creator>Diszházi, Gyula ; Magyar, Zsuzsanna Édua ; Mótyán, János András ; Csernoch, László ; Jóna, István ; Nánási, Péter Pál ; Almássy, János</creator><creatorcontrib>Diszházi, Gyula ; Magyar, Zsuzsanna Édua ; Mótyán, János András ; Csernoch, László ; Jóna, István ; Nánási, Péter Pál ; Almássy, János</creatorcontrib><description>Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers. Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purification procedure of RyR. Recently, Mg was demonstrated to be the essential factor for dantrolene to inhibit Ca release in skinned muscle fibers. The aim of the present study was to confirm these results in Ca release and bilayer experiments, using SR vesicles and solubilized channels, respectively. Our Ca release experiments demonstrated that the effect of dantrolene and Mg was cooperative and that ATP enhanced the inhibiting effect of dantrolene. Namely, 10 M dantrolene reduced RyR channel open probability by ∼50% in the presence of 3 mM free Mg and 1 mM ATP, whereas channel activity further decreased to ∼20% of control when [ATP] was increased to 2 mM. Our data provide important complementary information that supports the direct, Mg -dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.119.116475</identifier><identifier>PMID: 31337666</identifier><language>eng</language><publisher>United States</publisher><subject>Adenosine Triphosphate - metabolism ; Animals ; Binding Sites ; Calcium - metabolism ; Dantrolene - chemistry ; Dantrolene - pharmacology ; Magnesium - metabolism ; Male ; Models, Molecular ; Molecular Conformation ; Muscle, Skeletal - metabolism ; Protein Binding ; Rabbits ; Ryanodine Receptor Calcium Release Channel - chemistry ; Ryanodine Receptor Calcium Release Channel - metabolism</subject><ispartof>Molecular pharmacology, 2019-09, Vol.96 (3), p.401-407</ispartof><rights>Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883</citedby><cites>FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31337666$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diszházi, Gyula</creatorcontrib><creatorcontrib>Magyar, Zsuzsanna Édua</creatorcontrib><creatorcontrib>Mótyán, János András</creatorcontrib><creatorcontrib>Csernoch, László</creatorcontrib><creatorcontrib>Jóna, István</creatorcontrib><creatorcontrib>Nánási, Péter Pál</creatorcontrib><creatorcontrib>Almássy, János</creatorcontrib><title>Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers. Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purification procedure of RyR. Recently, Mg was demonstrated to be the essential factor for dantrolene to inhibit Ca release in skinned muscle fibers. The aim of the present study was to confirm these results in Ca release and bilayer experiments, using SR vesicles and solubilized channels, respectively. Our Ca release experiments demonstrated that the effect of dantrolene and Mg was cooperative and that ATP enhanced the inhibiting effect of dantrolene. Namely, 10 M dantrolene reduced RyR channel open probability by ∼50% in the presence of 3 mM free Mg and 1 mM ATP, whereas channel activity further decreased to ∼20% of control when [ATP] was increased to 2 mM. Our data provide important complementary information that supports the direct, Mg -dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Animals</subject><subject>Binding Sites</subject><subject>Calcium - metabolism</subject><subject>Dantrolene - chemistry</subject><subject>Dantrolene - pharmacology</subject><subject>Magnesium - metabolism</subject><subject>Male</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Protein Binding</subject><subject>Rabbits</subject><subject>Ryanodine Receptor Calcium Release Channel - chemistry</subject><subject>Ryanodine Receptor Calcium Release Channel - metabolism</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo9kM1Lw0AQxRdRbK1ePcreJXVnN_uRY6lVCxVFIngLu5uJjbRJ3KSH_veuVj0M82B-b-A9Qi6BTQF4erNtN1FkcVSq5REZg-SQMAA4JmPGuEpMJt9G5KzvPxiDVBp2SkYChNBKqTGZ39pmCO0GG6Qv-LmrA_b08Z3ya2qbks7yZ5q3dNmsa1cPdFhHam-btqx_eI_d0IZzclLZTY8Xv3tCXu8W-fwhWT3dL-ezVeKBaZVoXmqhnasg414ap8BU2nCPHBFZ6dB4LZWq4j0D5zPURionLbNMgDJGTMj08NeHtu8DVkUX6q0N-wJY8d1GEduIIisObUTD1cHQ7dwWy3_8L774Ah3mWWQ</recordid><startdate>201909</startdate><enddate>201909</enddate><creator>Diszházi, Gyula</creator><creator>Magyar, Zsuzsanna Édua</creator><creator>Mótyán, János András</creator><creator>Csernoch, László</creator><creator>Jóna, István</creator><creator>Nánási, Péter Pál</creator><creator>Almássy, János</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201909</creationdate><title>Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor</title><author>Diszházi, Gyula ; Magyar, Zsuzsanna Édua ; Mótyán, János András ; Csernoch, László ; Jóna, István ; Nánási, Péter Pál ; Almássy, János</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Animals</topic><topic>Binding Sites</topic><topic>Calcium - metabolism</topic><topic>Dantrolene - chemistry</topic><topic>Dantrolene - pharmacology</topic><topic>Magnesium - metabolism</topic><topic>Male</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Protein Binding</topic><topic>Rabbits</topic><topic>Ryanodine Receptor Calcium Release Channel - chemistry</topic><topic>Ryanodine Receptor Calcium Release Channel - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diszházi, Gyula</creatorcontrib><creatorcontrib>Magyar, Zsuzsanna Édua</creatorcontrib><creatorcontrib>Mótyán, János András</creatorcontrib><creatorcontrib>Csernoch, László</creatorcontrib><creatorcontrib>Jóna, István</creatorcontrib><creatorcontrib>Nánási, Péter Pál</creatorcontrib><creatorcontrib>Almássy, János</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diszházi, Gyula</au><au>Magyar, Zsuzsanna Édua</au><au>Mótyán, János András</au><au>Csernoch, László</au><au>Jóna, István</au><au>Nánási, Péter Pál</au><au>Almássy, János</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2019-09</date><risdate>2019</risdate><volume>96</volume><issue>3</issue><spage>401</spage><epage>407</epage><pages>401-407</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers. Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purification procedure of RyR. Recently, Mg was demonstrated to be the essential factor for dantrolene to inhibit Ca release in skinned muscle fibers. The aim of the present study was to confirm these results in Ca release and bilayer experiments, using SR vesicles and solubilized channels, respectively. Our Ca release experiments demonstrated that the effect of dantrolene and Mg was cooperative and that ATP enhanced the inhibiting effect of dantrolene. Namely, 10 M dantrolene reduced RyR channel open probability by ∼50% in the presence of 3 mM free Mg and 1 mM ATP, whereas channel activity further decreased to ∼20% of control when [ATP] was increased to 2 mM. Our data provide important complementary information that supports the direct, Mg -dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.</abstract><cop>United States</cop><pmid>31337666</pmid><doi>10.1124/mol.119.116475</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 2019-09, Vol.96 (3), p.401-407
issn 0026-895X
1521-0111
language eng
recordid cdi_crossref_primary_10_1124_mol_119_116475
source Free Full-Text Journals in Chemistry
subjects Adenosine Triphosphate - metabolism
Animals
Binding Sites
Calcium - metabolism
Dantrolene - chemistry
Dantrolene - pharmacology
Magnesium - metabolism
Male
Models, Molecular
Molecular Conformation
Muscle, Skeletal - metabolism
Protein Binding
Rabbits
Ryanodine Receptor Calcium Release Channel - chemistry
Ryanodine Receptor Calcium Release Channel - metabolism
title Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A52%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dantrolene%20Requires%20Mg%202+%20and%20ATP%20To%20Inhibit%20the%20Ryanodine%20Receptor&rft.jtitle=Molecular%20pharmacology&rft.au=Diszh%C3%A1zi,%20Gyula&rft.date=2019-09&rft.volume=96&rft.issue=3&rft.spage=401&rft.epage=407&rft.pages=401-407&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.119.116475&rft_dat=%3Cpubmed_cross%3E31337666%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/31337666&rfr_iscdi=true